publication venue for
- Glucagon-like Peptide-1 receptor agonists for the prevention and treatment of Parkinson's disease.. 30:-. 2025
- A systematic review of anti-suicidal effects of sedative-hypnotics and cognitive behavioral therapy for insomnia.. 30:-. 2025
- Association of antidepressants with cataracts and glaucoma: a disproportionality analysis using the reports to the United States Food and Drug Administration Adverse Event Reporting System (FAERS) pharmacovigilance database.. 29:682-696. 2025
- Impact of depressive symptoms on motivation in persons with post-COVID-19 condition.. 29:665-669. 2024
- A systematic review on the efficacy of GLP-1 receptor agonists in mitigating psychotropic drug-related weight gain.. 1-7. 2024
- Efficacy of esketamine for perinatal depression: a systematic review and meta-analysis.. 1-9. 2024
- The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia.. 28:1-20. 2022
- Open innovation: the key to advancing brain health.. 28:1-3. 2022
- Dementia-related psychosis and the potential role for pimavanserin.. 27:7-15. 2020
- Use of magnetic resonance imaging to identify mild cognitive impairment: who should be imaged?. 13:18-20. 2008
- The pathogenesis of Alzheimer's disease and the role of Abeta42.. 12:4-6. 2007
- Medical burden, cerebrovascular disease, and cognitive impairment in geriatric depression: modeling the relationships with the CART analysis.. 7:716-22. 2002
- Neuropsychological performance changes following subthalamic versus pallidal deep brain stimulation in Parkinson's disease: A systematic review and metaanalysis 2018
- Neuropsychological performance changes following subthalamic versus pallidal deep brain stimulation in Parkinson’s disease: a systematic review and metaanalysis 2017